Roche Diagnostics Korea announced on the 24th that it successfully held the Roche Diagnostics Digital Pathology Insight 2024 Symposium over two days, from the 20th to the 21st, at the InterContinental Seoul COEX in Gangnam-gu, Seoul.
Participants of the Roche Diagnostics Digital Pathology Insight 2024 Symposium are taking a commemorative photo. [Photo by Korea Roche Diagnostics]
The Roche Digital Pathology Symposium, held for the first time this year, was an event planned by Roche Diagnostics Asia-Pacific (APAC) regional headquarters targeting digital pathology experts both domestically and internationally. It was explained that Korea was chosen as the host country considering the advanced status of digital pathology in Korea. The symposium introduced Roche’s AI platform, including digital pathology scanners, software, and algorithms, to digital pathology experts from home and abroad, while also facilitating important discussions on expanding the domestic digital pathology market.
On the first day of the symposium, Professor Chan-Kwon Jung from the Department of Pathology at Seoul St. Mary’s Hospital, The Catholic University of Korea, delivered a lecture titled “The Road to Success in Digital Pathology: Case Studies and Shared Perspectives,” and Professor Kyung-Bun Lee from the Department of Pathology at Seoul National University Hospital gave a lecture on “Digital Pathology Diagnostic Efficiency and Accuracy ? Sharing Insights.” This was followed by a discussion on “Utilization Cases of Digital Pathology Across the Asia-Pacific (APAC) Market.” Subsequently, a panel discussion on “Limitations in the Adoption of Digital Pathology” addressed overcoming the slow establishment of digital pathology environments due to the initially high entry barriers despite various advantages.
Digital pathology facilitates converting traditional glass slides into high-resolution image files and using algorithms to provide more objective pathological diagnostic information to patients and medical staff. Additionally, digital pathology enables smooth data transfer between hospitals, helping to reduce regional and hospital-based healthcare disparities and lessen patients’ psychological and economic burdens.
On the second day of the event, the 21st, participants visited the GC Green Cross Medical Foundation to experience Korea’s advanced digital pathology laboratory. Joo-Young Heo, Head of the Pathology Division at GC Green Cross Medical Foundation, said, “We are pleased to introduce Korea’s advanced digital pathology laboratory to digital experts from home and abroad,” adding, “The greatest advantage of digital pathology is not only increasing testing efficiency but also providing objective and highly accurate pathological diagnostic results, which improve patients’ treatment journeys and positively impact treatment outcomes.”
Following this, Yvonne Yap, Head of Digital Insight Business at Roche Diagnostics APAC, introduced “Digitalization of Healthcare through an Open Ecosystem,” and Kyung-Hyun Paeng, Director at Lunit, gave a lecture titled “Startup Innovation in Digital Pathology: Providing Algorithm Solutions,” creating an opportunity to discuss the scalability and future of digital pathology. The final session featured an expert panel discussion on the evolving digital pathology with domestic and international digital pathology experts.
Kit Tang, CEO of Roche Diagnostics Korea, said, “It was a meaningful time to network with domestic and international digital pathology experts and discuss the limitations and ways to overcome the adoption of digital pathology,” adding, “Roche Diagnostics Korea will continue the spirit of collaboration and innovation initiated at this symposium and strengthen all necessary activities to advance digital pathology and improve patient health.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
